Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vycor MedicalVYCO EBITDA Margin % is 13.29% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Vycor Medical ranks better than 51.41% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Vycor Medical's EBITDA for the
three
months ended in Mar. 2026 was $0.06 Mil. Vycor Medical's Revenue for the
three
months ended in Mar. 2026 was $0.46 Mil. Therefore, Vycor Medical's EBITDA margin for the quarter that ended in Mar. 2026 was 13.29%.
Vycor Medical (OTCPK:VYCO) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Vycor Medical EBITDA Margin % Related Terms
Vycor Medical EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Vycor Medical's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VYCO vs AEMD, VTAK, ALURD: EBITDA Margin % Comparison
For the Medical Devices subindustry, Vycor Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Vycor Medical's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (VYCO) has a EBITDA Margin % of 13.29% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vycor Medical and its competitors. According to the industry distribution chart, Vycor Medical ranks #396 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 48.6%.
Is Vycor Medical's EBITDA Margin % too high?
Vycor Medical's current EBITDA Margin % is 13.29%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.47. Vycor Medical's value of 13.29% is 77.9% above this industry median. Based on the distribution chart, Vycor Medical ranks #396 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Vycor Medical's EBITDA Margin % compare to AEMD and VTAK?
According to the Medical Devices & Instruments industry distribution chart, Vycor Medical ranks #396 out of 815 companies for EBITDA Margin %. This puts Vycor Medical in the upper half of its industry. The industry median EBITDA Margin % is 7.47. Vycor Medical's value of 13.29% is 77.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vycor Medical's current EBITDA Margin % of 13.29% is 77.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Vycor Medical and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vycor Medical's current EBITDA Margin % is 13.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vycor Medical stock overvalued right now?
Based on GuruFocus' analysis, Vycor Medical (VYCO) is currently considered Possible Value Trap. The stock's GF Value™ is $0.12, compared to a current price of $0.07 — trading 42.5% below its estimated fair value. The current EBITDA Margin % is 13.29% and 77.9% above the Medical Devices & Instruments industry median of 7.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Vycor Medical (VYCO), the current EBITDA Margin % is 13.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vycor Medical Inc provides the medical community with superior surgical and therapeutic solutions and operates two distinct business units within the medical device industry. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage such as that caused by a stroke. The company operates in two segments, Vycor Medical and NovaVision, with the majority of the revenue been derived from Vycor Medical segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VYCO has been successfully added to your 
